Last reviewed · How we verify
Tozinameran 6 months to 4 years of age (tozinameran-6-months-to-4-years-of-age)
Tozinameran 6 months to 4 years of age (generic name: tozinameran-6-months-to-4-years-of-age) is a vaccine drug developed by Pfizer. It is currently FDA-approved for Prevention of COVID-19 in individuals 6 months of age and older.
Tozinameran is a COVID-19 vaccine developed by Pfizer Inc. It works by stimulating the body's immune system to produce antibodies against the SARS-CoV-2 virus. The vaccine is indicated for the prevention of COVID-19 in individuals 6 months of age and older. It has been marketed and has generated significant revenue. Tozinameran is a novel vaccine that has shown clinical differentiation in its ability to prevent severe COVID-19. Its commercial significance is evident in its high revenue. There are no pipeline developments mentioned.
At a glance
| Generic name | tozinameran-6-months-to-4-years-of-age |
|---|---|
| Sponsor | Pfizer |
| Drug class | vaccine |
| Target | SARS-CoV-2 spike protein |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Prevention of COVID-19 in individuals 6 months of age and older
Common side effects
Drug interactions
- Live, intranasal influenza vaccines
- Live vaccines
- Vaccines (non-live)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tozinameran 6 months to 4 years of age CI brief — competitive landscape report
- Tozinameran 6 months to 4 years of age updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Tozinameran 6 months to 4 years of age
What is Tozinameran 6 months to 4 years of age?
What is Tozinameran 6 months to 4 years of age used for?
Who makes Tozinameran 6 months to 4 years of age?
What is the generic name of Tozinameran 6 months to 4 years of age?
What drug class is Tozinameran 6 months to 4 years of age in?
What development phase is Tozinameran 6 months to 4 years of age in?
What does Tozinameran 6 months to 4 years of age target?
Related
- Drug class: All vaccine drugs
- Target: All drugs targeting SARS-CoV-2 spike protein
- Manufacturer: Pfizer — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of COVID-19 in individuals 6 months of age and older
- Compare: Tozinameran 6 months to 4 years of age vs similar drugs
- Pricing: Tozinameran 6 months to 4 years of age cost, discount & access